Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Genetics
|
July 1, 1983
Marker rescue from bleomycin-treated Chlamydomonas reinhardi
D E Hourcade
Immunopharmacology
|
July 17, 1999
Decay acceleration of the complement alternative pathway C3 convertase
D E Hourcade, L M Mitchell, M E Medof
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 1999
Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding
D E Hourcade, L M Mitchell, T J Oglesby
The Journal of Biological Chemistry
|
August 25, 1995
Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis
D E Hourcade, L M Wagner, T J Oglesby
The Journal of Biological Chemistry
|
September 25, 1998
A conserved element in the serine protease domain of complement factor B
D E Hourcade, L M Mitchell, T J Oglesby
Journal of Immunology (Baltimore, Md. : 1950)
|
August 8, 2001
Characterization of the active sites in decay-accelerating factor
L A Kuttner-Kondo, L Mitchell, D E Hourcade, et al.
The Journal of Biological Chemistry
|
October 26, 1999
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases
M Krych-Goldberg, R E Hauhart, V B Subramanian, et al.
Transfusion
|
March 16, 2002
Expansion of the Knops blood group system and subdivision of Sl(a)
J M Moulds, P A Zimmerman, O K Doumbo, et al.
Molecular Immunology
|
March 21, 2007
The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation
D Kavanagh, R Burgess, D Spitzer, et al.
Blood
|
April 21, 2001
Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1
J M Moulds, P A Zimmerman, O K Doumbo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Genetics
|
July 1, 1983
Marker rescue from bleomycin-treated Chlamydomonas reinhardi
D E Hourcade
Immunopharmacology
|
July 17, 1999
Decay acceleration of the complement alternative pathway C3 convertase
D E Hourcade, L M Mitchell, M E Medof
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 1999
Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding
D E Hourcade, L M Mitchell, T J Oglesby
The Journal of Biological Chemistry
|
August 25, 1995
Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis
D E Hourcade, L M Wagner, T J Oglesby
The Journal of Biological Chemistry
|
September 25, 1998
A conserved element in the serine protease domain of complement factor B
D E Hourcade, L M Mitchell, T J Oglesby
Journal of Immunology (Baltimore, Md. : 1950)
|
August 8, 2001
Characterization of the active sites in decay-accelerating factor
L A Kuttner-Kondo, L Mitchell, D E Hourcade, et al.
The Journal of Biological Chemistry
|
October 26, 1999
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases
M Krych-Goldberg, R E Hauhart, V B Subramanian, et al.
Transfusion
|
March 16, 2002
Expansion of the Knops blood group system and subdivision of Sl(a)
J M Moulds, P A Zimmerman, O K Doumbo, et al.
Molecular Immunology
|
March 21, 2007
The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation
D Kavanagh, R Burgess, D Spitzer, et al.
Blood
|
April 21, 2001
Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1
J M Moulds, P A Zimmerman, O K Doumbo, et al.
Page
of 1